» Articles » PMID: 24363643

ATP P2X3 Receptors and Neuronal Sensitization

Overview
Specialty Cell Biology
Date 2013 Dec 24
PMID 24363643
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Increasing evidence indicates the importance of extracellular adenosine triphosphate (ATP) in the modulation of neuronal function. In particular, fine control of ATP release and the selective and discrete ATP receptor operation are crucial elements of the crosstalk between neuronal and non-neuronal cells in the peripheral and central nervous systems. In peripheral neurons, ATP signaling gives an important contribution to neuronal sensitization, especially that involved in neuropathic pain. Among other subtypes, P2X3 receptors expressed on sensory neurons are sensitive even to nanomolar concentrations of extracellular ATP, and therefore are important transducers of pain stimuli. P2X3 receptor function is highly sensitive to soluble factors like neuropeptides and neurotrophins, and is controlled by transduction mechanisms, protein-protein interactions and discrete membrane compartmentalization. More recent findings have demonstrated that P2X3 receptors interact with the synaptic scaffold protein calcium/calmodulin-dependent serine protein kinase (CASK) in a state dependent fashion, indicating that CASK plays a crucial role in the modulation of P2X3 receptor stability and efficiency. Activation of P2X3 receptors within CASK/P2X3 complex has important consequences for neuronal plasticity and possibly for the release of neuromodulators and neurotransmitters. Better understanding of the interactome machinery of P2X3 receptors and their integration with other receptors and channels on neuronal surface membranes, is proposed to be essential to unveil the process of neuronal sensitization and related, abnormal pain signaling.

Citing Articles

P2X3 Receptor Antagonist Eliapixant in Phase I Clinical Trials: Safety and Inter-ethnic Comparison of Pharmacokinetics in Healthy Chinese and Japanese Participants.

Li X, Haranaka M, Li H, Liu P, Chen H, Klein S Clin Pharmacokinet. 2024; 63(6):901-915.

PMID: 38907175 DOI: 10.1007/s40262-024-01387-y.


Efficacy and safety of eliapixant in endometriosis-associated pelvic pain: the randomized, placebo-controlled phase 2b SCHUMANN study.

Parke S, Gude K, Roth K, Messina F BMC Womens Health. 2024; 24(1):353.

PMID: 38890641 PMC: 11186168. DOI: 10.1186/s12905-024-03188-8.


Metabolic network analysis of pre-ASD newborns and 5-year-old children with autism spectrum disorder.

Lingampelly S, Naviaux J, Heuer L, Monk J, Li K, Wang L Commun Biol. 2024; 7(1):536.

PMID: 38729981 PMC: 11549098. DOI: 10.1038/s42003-024-06102-y.


Mass Balance and Metabolic Pathways of Eliapixant, a P2X3 Receptor Antagonist, in Healthy Male Volunteers.

Reif S, Schultze-Mosgau M, Engelen A, Piel I, Denner K, Roffel A Eur J Drug Metab Pharmacokinet. 2023; 49(1):71-85.

PMID: 38044419 DOI: 10.1007/s13318-023-00866-0.


Benzydamine plays a role in limiting inflammatory pain induced by neuronal sensitization.

Nikolaeva-Koleva M, Espinosa A, Vergassola M, Polenzani L, Mangano G, Ragni L Mol Pain. 2023; 19:17448069231204191.

PMID: 37710969 PMC: 10583526. DOI: 10.1177/17448069231204191.


References
1.
Simonetti M, Giniatullin R, Fabbretti E . Mechanisms mediating the enhanced gene transcription of P2X3 receptor by calcitonin gene-related peptide in trigeminal sensory neurons. J Biol Chem. 2008; 283(27):18743-52. DOI: 10.1074/jbc.M800296200. View

2.
Fabbretti E, Nistri A . Regulation of P2X3 receptor structure and function. CNS Neurol Disord Drug Targets. 2012; 11(6):687-98. DOI: 10.2174/187152712803581029. View

3.
Ford A . In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization. Purinergic Signal. 2011; 8(Suppl 1):3-26. PMC: 3265711. DOI: 10.1007/s11302-011-9271-6. View

4.
Bardoni R, Goldstein P, Lee C, Gu J, Macdermott A . ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord. J Neurosci. 1997; 17(14):5297-304. PMC: 6793828. View

5.
Gnanasekaran A, Sundukova M, Hullugundi S, Birsa N, Bianchini G, Hsueh Y . Calcium/calmodulin-dependent serine protein kinase (CASK) is a new intracellular modulator of P2X3 receptors. J Neurochem. 2013; 126(1):102-12. DOI: 10.1111/jnc.12272. View